Amyloidosis: Review and CT manifestations

Radiographics

Volumn 24, Issue 2, 2004, Pages 405-416

  Georgiades, Christos S ^a   Neyman, Edward G ^a   Barish, Matthew A ^b   Fishman, Elliot K ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Amyloidosis, **.682; Myeloma, **.34; Proteins, **.68

Indexed keywords

AMYLOIDOSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; PATIENT CARE; PREVALENCE; REVIEW;

EID: 1842731139     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/rg.242035114     Document Type: Review

References (22)

1. Hawkins PN. Amyloidosis. Blood Rev 1995; 9:135-142.
2. Dhodapkar MV, Merlini G, Solomon A. Biology and therapy of immunoglobulin deposition diseases. Hematol Oncol Clin North Am 1997; 11: 89-110.
3. Rubin E, Farber JL. Pathology. 2nd ed. Philadelphia, Pa: Lippincott, 1994.
4. Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee. Bull World Health Organ 1993; 71:105-112.
5. Gertz MA, Kyle RA. Amyloidosis with IM monoclonal gammopathies. Semin Oncol 2003; 30:325-328.
6. Joss N, McLaughlin K, Simpson K, Boulton-Jones JM. Presentation, survival and prognostic markers in AA amyloidosis. QJM 2000; 93:535-542.
7. Pasqualetti P, Casale R. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Biomed Pharmacother 1997; 51:74-78.
8. Hattori K, Irie S, Isobe Y, et al. Multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia. Ann Hematol 1998; 77:179-181.
9. Maniatis A. Pathophysiology of paraprotein production. Ren Fail 1998; 20:821-828.
10. Dhodapkar MV, Merlini G, Solomon A. Biology and therapy of immunoglobulin deposition diseases. Hematol Oncol Clin North Am 1997; 11: 89-110.
11. Lovat LB, Pepys MB, Hawkins PN. Amyloid and the gut. Dig Dis 1997; 15:155-171.
12. Araoz PA, Batts KP, MacCarty RL. Amyloidosis of the alimentary canal: radiologic-pathologice correlation of CT findings. Abdom Imaging 2000; 25:38-44.
13. Friedman S, Janowitz HD. Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin North Am 1998; 27:595-614.
14. Georgiades CS, Neyman EG, Fishman EK. Cross-sectional imaging of amyloidosis: an organ system-based approach. J Comput Assist Tomogr 2002; 26:1035-1043.
15. Kingman A, Pereira NL. Cardiac amyloidosis. J S C Med Assoc 2001; 97:201-206.
16. Cacoub P, Axler O, De Zuttere D, et al. Amyloidosis and cardiac involvement. Ann Med Interne (Paris) 2000; 151:611-617.
17. Mehta SK, Cogan J, Reimold SC, De Lemos JA. Primary systemic amyloidosis presenting with advanced heart failure. Cardiol Rev 2003; 11:152-155.
18. O'Regan A, Fenlon HM, Beamis JF Jr, Steele MP, Skinner M, Berk JL. Tracheobronchial amyloidosis: the Boston University experience from 1984 to 1999. Medicine (Baltimore) 2000; 79:69-79.
19. Kim HY, Im JG, Song KS, et al. Localized amyloidosis of the respiratory system: CT features. J Comput Assist Tomogr 1999; 23:627-631.
20. Howard ME, Ireton J, Daniels F, et al. Pulmonary presentations of amyloidosis. Respirology 2001; 6:61-64.
21. Paydas S. Report on 59 patients with renal amyloidosis. Int Urol Nephrol 1999; 31:619-631.
22. Sasatomi Y, Kiyoshi Y, Uesugi N, Hisano S, Takebayashi S. Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis. Nephron 2001; 87:42-49.